this review is to summarize the observations that already disease. An increased understanding of the molecular genetic have been made and to discuss therapies for PKD that and cellular pathophysiologic mechanisms responsible for the deserve investigation. development of autosomal-dominant polycystic kidney disease (ADPKD), made possible by the advances in molecular biology and genetics of the last three decades, has laid the foundation
not affected by the germline mutation. The analysis of X chromosome inactivation patterns in epithelial cells, isolated from individual cysts from women with ADPKD, Adult polycystic kidney disease (PKD) was once has suggested that cysts develop from clonal expansions deemed to be a rare congenital malformation with a fate of single cells. Analysis of the PKD1 genes in these predetermined at birth. Recognition of its hereditary cells has revealed a loss of heterozygosity or intragenic nature nearly a century ago (autosomal-dominant PKD mutations involving the nonaffected PKD1 allele in apor ADPKD) added to the burden of affected individuals.
proximately 20% of renal and hepatic cysts [reviewed More recent studies have shown that the ADPKD kidney in 1] and similar changes involving the PKD2 gene in forms normally and that macroscopic cysts develop PKD2 cystic epithelium [7-9]. These observations supmainly after birth. It is the most common life-threatening port a two-hit model of cystogenesis, which is consistent monogenetic human disease and the third most common with the inactivating nature of most germline PKD1 and single cause of end-stage renal failure behind hyperten-PKD2 mutations [10, 11] and the focal development of sion and diabetes mellitus. Advances in molecular biolrenal and hepatic cysts. The mild cystic phenotype of ogy and genetics in the last three decades have made Pkd1 or Pkd2 heterozygote and the severe fetal cystic possible a greater understanding of the molecular genetic changes of homozygote mutant mice indicate that cystoand cellular pathophysiologic mechanisms responsible genesis is associated with polycystin loss [2] . The more for the development of ADPKD, and have laid the founsevere cystic disease in Pkd2 WS25/WS25 and Pkd2 WS25/Ϫ mice, dation for the development of effective therapies [reassociated with the Pkd2 WS25 unstable allele (generviewed in [1] [2] [3] [4] . As the concept that a polycystic kidney ated by tandem integration of a mutant exon 1 into the is a neoplasm in disguise is gaining acceptance [5] , the first intron of Pkd2), which results in an increased rate development of therapies for ADPKD may benefit from of somatic mutations by intragenic homologous recombithe expanding body of information on cancer chemonation, further supports the two-hit mechanism. The mild prevention and chemosuppression [6] . The purpose of cystic phenotype of Pkd1 or Pkd2 heterozygote mutant mice [12, 13] may point to different susceptibilities of murine Pkd and human PKD genes to somatic mutations. mutations by gene conversion events [15] . The high rate [28, 29] . If these transheterozygous mutations are pathogenetically important, it seems likely that mutations in of somatic mutations in the PKD2 gene remains unexplained. Of note is the variable development of the ex-multiple other genes encoding proteins that may be partners of the polycystins in the same signaling pathway pected renal phenotype in other targeted mutant mouse models for diseases in which a two-hit mechanism is may also occur. The understanding of the molecular genetic mecha-likely. For example, heterozygote mutant mice for Von Hippel-Lindau (VHL) disease remain phenotypically nisms responsible for the cystic disease in ADPKD has treatment implications. If somatic mutations of either normal up to 15 months of age [16] , while heterozygote tuberous sclerosis complex 2 (TSC2) mutant mice consis-one or multiple genes were important, treatments directed at reducing the rate of mutations should be consid-tently develop renal cell carcinomas by 6 months of age [17] . Therefore, other mechanisms may need to be con-ered. Their effectiveness would depend on whether the somatic mutations occur mostly during the development, sidered to account for the different phenotypic expression of PKD mutations in humans and mice. The differ-maturation, and growth of the kidney or at later stages in association with environmental exposures and cellular ent phenotypic expression of these diseases may simply reflect differences in life span, which determines whether senescence. If the hypothesis that ADPKD is a recessive disease at the cellular level was confirmed, gene replace-somatic mutations develop in the kidney, an organ that may be particularly susceptible because of its high oxida-ment therapy would be theoretically possible. The feasibility of gene replacement therapy has been demon-tive metabolism [18] , as well as other factors that currently are not understood. strated by the rescue of the renal phenotype in the Oak Ridge National Laboratory polycystic kidney (orpk) Whether somatic mutations of the PKD allele not affected by the germline mutation are the only, or even model by the expression of the wild-type orpk gene as a transgene [30] . The expression of PKD1 as a transgene the most important, mechanism responsible for cyst formation in ADPKD has not been definitely established.
has also been shown to rescue the embryonically lethal The overexpression of polycystin 1 in the cystic epithephenotype associated with the Pkd1 del34/del34 knock-out lium detected immunohistochemically by C-terminal anmouse [27] . Technical considerations, such as the retibodies [reviewed in 4] can only be explained, within quirement for a highly selective, efficient, and durable the context of the two-hit model, if the majority of second gene transfer to somatic cells, safety issues, and the obhits involve in-frame missense mutations rather than servation that the overexpression of PKD1 also results truncations or deletions. This may be particularly imporin a cystic phenotype cast doubt on the feasibility of tant in the TSC2/PKD1 contiguous gene syndrome and gene therapy as a successful treatment for ADPKD. in early ADPKD, in which overexpression of polycystin 1 is more uniformly observed [19] . The extensive renal THE FUNCTION OF POLYCYSTINS cystic disease observed in the PKD1/TSC2 contiguous The predicted structures of the polycystins suggest gene syndrome and early onset ADPKD would require that they are membrane-associated proteins capable of an extremely high rate of somatic mutations or somatic physical interaction, but their function remains uncertain mutations occurring in stem cells at an early stage of [reviewed in [1] [2] [3] [4] . Recent evidence supports the concept nephrogenesis. If the latter was correct, many cysts in that they participate in the regulation of cell-matrix and these conditions would share the same somatic mutacell-cell interactions and, by so doing, of cell differentiations, a hypothesis that has not yet been tested. The tion, proliferation, and apoptosis. Polycystin 1 has been increased rate of proliferation and apoptosis observed found to be a component of large multiprotein complexes in many noncystic tubules cannot be explained by the associated with cell-matrix contacts at focal adhesions two-hit hypothesis unless the rate of second hits is much and intercellular contacts at adherens junctions and deshigher than that suggested by the number of cysts [20] [21] [22] . mosomes [31, 32] . Polycystin 2 is expressed in the endo-Focal development of cysts has also been observed in plasmic reticulum membrane of cells in tissue culture, autosomal recessive models [22, 23] , as well as in transand its C-terminus contains a 34 amino acid region essengenic models of PKD [24] [25] [26] . Overexpression of PKD1 tial to this localization [33] . Possibly the physical interacas a transgene results in the development of a cystic tion between polycystin 1 and polycystin 2 is important phenotype, suggesting that the maintenance of a normal for the trafficking of these proteins to the plasma memlevel of polycystin may be critical to maintain a differenbrane. tiated tubular epithelial phenotype [27] . Transheterozy-Cell-matrix interactions in focal adhesions are medigous mutations of PKD1 and PKD2 (for example, soated by integrin receptors (Fig. 1 ). These are heterodimatic mutations of PKD2 in cells carrying a germline meric molecules composed of ␣ and ␤ subunits, of which PKD1 mutation) have been recently reported and prothere are multiple subtypes with specificity of binding to posed to explain the continued expression of polycystin 1 and polycystin 2 in ADPKD1 and ADPKD2 kidneys different matrix components [34] . Binding to specific ligands induces clustering of integrin heterodimers and the adherens junction and desmosomes and by ubiquitinproteasome-mediated degradation following phosphoryla-assembly of a multiprotein complex, which includes structural actin binding proteins such as tensin, vinculin, talin, tion by glycogen synthase kinase-3␤ (Gsk3␤) in a multiprotein complex that also includes the adenomatous polyposis and ␣-actinin, as well as the tyrosine kinases focal adhesion kinase (FAK) and c-src. This provides a mechanism coli (APC) protein, axin, and protein phosphatase-2A.
The degradation of ␤-catenin can be inhibited by secreted for signal transduction leading to alterations in gene transcription. Cell-cell interactions at adherens junctions and Wnt glycoprotein acting upon its receptor Frizzled, which activates Disheveled (Dvl) and inhibits Gsk3␤. Free cyto-desmosomes are mediated by classic and desmosomal cadherins ( Fig. 1) . These are single-pass transmembrane solic ␤-catenin can translocate to the nucleus, where it binds and activates the lymphoid-enhancing transcription adhesion proteins, capable of forming lateral dimers in a calcium-dependent manner [35] . The cytoplasmic do-factor (LEF-1) T-cell factor (TCF). One of the target genes of the ␤-catenin/LEF-1 transcription factor is c-myc, mains of these proteins connect directly to ␤-catenin or ␥-catenin, which function as a bridge with ␣-catenin and which is overexpressed in PKD. The precise localization and the role of polycystins in cytoskeleton molecules such as ␣-actinin, vinculin, and F-actin. There is evidence for cross-talk between focal cell-matrix and cell-cell contacts are not firmly established. Wilson et al have detected a direct physical associ-and adherens junctions. In many cellular systems, cadherin activity is under the dual control of signaling path-ation between polycystin 1 and ␣ 2 and ␤ 1 integrins, vinculin, paxillin, and FAK during the initial adherence of ways activated by focal adhesions and growth factor receptors. Tyrosine phosphorylation of the NH 2 -terminus fetal collecting tubule epithelial cells to type 1 collagen matrix [31] . On the other hand, Huan and van Adelsberg of ␤-catenin results in dissociation of the entire cadherin catenin complex from the cytoskeleton.
have observed the colocalization of polycystin 1 with E-cadherin and ␣, ␤, and ␥-catenins, but not with FAK ␤-Catenin is a bifunctional protein that is not only involved in cell-cell adhesion by its link to E-cadherin, or ␤ 1 -integrin, in human fetal kidney [32] . Scheffers et al have reported the colocalization of polycystin 1 with des-but also functions as a transcription factor ( Fig. 1) [36, 37] . Cytosolic ␤-catenin levels are regulated by binding to mosomes (abstract; Scheffers M, Netherlands PKD Work-shop, 2000). These different results may reflect the state because of an impaired basolateral trafficking of proteins and a delayed exit from the Golgi apparatus [42] . The of maturity of the epithelial cells. Thus, in subconfluent cells, polycystin 1 may associate with classic proteins of reduced levels of E-cadherin in the cystic epithelium may explain the increased rate of apoptosis in ADPKD kidneys focal adhesions, while it forms multiprotein complexes typical of adherens junctions and desomosomes in con-since cell-cell adhesion inhibits apoptosis in the renal tubules by an E-cadherin-dependent mechanism [43] . In fluent epithelia.
The mechanisms by which a loss or reduced level of addition, the reduced sequestration of ␤-catenin by the E-cadherin complexes may result in higher cytoplasmic polycystin 1 might disrupt normal cell-matrix or cell-cell interactions are just beginning to be ascertained. Several levels. Consistent with this is the observation by Huan and van Adelsberg of a prolonged half-life of ␤-catenin in investigators have described abnormal cell-matrix interactions in ADPKD-derived epithelial cells. Wilson et al immortalized cell lines isolated from cpk mice (abstract; Huan Y, 33rd ASN Meeting, 2000) . An important role for found that ADPKD-derived cells express higher levels of ␣ 2 and ␤ 1 integrins and matrix attachment compared ␤-catenin in the pathogenesis of ADPKD is also supported by the observations that transgenic mice expressing large with normal epithelial cells. In addition, they were able to coimmunoprecipitate polycystin 1 and FAK from nor-amounts of a NH2-terminally truncated ␤-catenin develop severe PKD [44] , that the expression of c-myc (a mal, but not from ADPKD, epithelial cell extracts and suggested that an alteration in polycystin 1 phosphoryla-target of ␤-catenin/LEF-1) is up-regulated in the cystic epithelium from human ADPKD and rodent models of tion, resulting from an impaired association with FAK, could be responsible for a failure to down-regulate integ-PKD, that overexpression of c-myc as a transgene induces the development of PKD [26] , and that treatment rin-mediated epithelial cell adhesion [31] . Huan and van Adelsberg also observed an increased ␤ 1 integrin-medi-with c-myc antisense oligonucleotides reduced the severity of the cystic disease in cpk/cpk mice (abstract; Ricker ated adhesion to extracellular matrix in cells from polycystic kidneys in the cpk mouse. These investigators, J, 32nd ASN Meeting, 1999). If the role of ␤-catenin in however, suggested that the up-regulation of ␤ 1 integrinthe pathogenesis of PKD is confirmed, treatment stratemediated adhesion was secondary to a disruption of the gies to down-regulate its expression or activity could be normal interaction between polycystin 1 and the E-cadconsidered. herin/catenin complexes, and that it might represent an example of cross-talk between cadherins and integrins DOWNSTREAM PATHOGENETIC EVENTS [32] . Daikha-Dahmane et al found a marked increase in While the exact molecular genetic and biochemical ␣ 1 integrin staining in normal and cystic collecting duct mechanisms that initiate the development of the cystic cells and a severe disorganization of the expression and disease in ADPKD have not been firmly established, distribution of other integrins in the cyst lining cells from they result in a clonal expansion of partially differenti-ADPKD and ARPKD kidneys [38] . The role of cellated epithelial cells characterized by disregulation of epimatrix interactions in the pathogenesis of PKD is supthelial cell proliferation and apoptosis, expression of a ported by the renal cystic phenotype of tensin knockout secretory phenotype, and a disarray of cell matrix intermice [39] .
actions that leads to interstitial inflammation and matrix A number of recent studies suggest that polycystin 1 accumulation ( Fig. 2 ). In addition, the cysts produce a participates in the regulation of cell-cell interactions in number of factors capable of affecting in an autocrine renal tubular epithelial cells and that a disruption of these and paracrine fashion the development and enlargement interactions may be an early event in the pathogenesis of neighboring cysts. These include growth factors, cheof ADPKD. Rocco et al first reported an attenuated exmokines, proinflammatory cytokines, nucleotides, bioacpression of the epithelial cell adhesion molecules N-CAM tive lipids, matrix metalloproteinases, lysosomal enzymes, and E-cadherin at mRNA and protein levels in the kidand vasoactive factors [reviewed in 45, 46] . Recent microneys of cpk/cpk mice, and suggested that a defect in cell puncture and microdissection studies have demonstrated adhesion receptors in the cystic renal epithelium may that tubular obstruction is a feature of PKD in some animal play an important role in the pathogenesis of cyst formamodels and may contribute to the growth, if not the tion and altered function of cystic epithelium [40] . More development, of the cysts [47] . Several investigators have recently, Kim et al observed that the expression of the drawn attention to the similarities between the patho-C-terminal domain of polycystin as a membrane-bound genesis of renal cystic disease and obstructive nephropafusion protein stabilizes soluble endogenous ␤-catenin thy. Nephroangiosclerosis develops early in ADPKD and stimulates LEF-1-dependent gene transcription in and probably contributes significantly to the progression human embryonic kidney cells [41] . Charron et al have of the renal disease and decline in renal function. Parireported that the epithelial cells from polycystic kidneys passu with this downstream pathogenetic event, the analnot only have reduced levels of E-cadherin, but that this protein is improperly sequestered in an intracellular pool ysis of the signal transduction pathways in cells derived from cystic epithelium has demonstrated multiple abnor-late the development of PKD and be a target for therapy would be warranted. malities (Fig. 3 ). The increasing understanding of the Oxidant species are generated during metabolic proabnormalities in cell-matrix and cell-cell communication, cesses and contribute to the regulation of cell proliferaendocrine, paracrine and autocrine mechanisms, and sigtion and differentiation under normal conditions and to nal transduction pathways in ADPKD has provided a tissue injury in response to pathologic stresses. Damage framework for the delineation of possible therapies and to DNA by oxidant species appears to occur naturally, opportunities for synergistic interventions in ADPKD. and low steady-state levels of base-damaged products can be detected in nuclear DNA from human cells and ANTIMUTAGENS AND ANTIOXIDANTS tissues. It has been calculated that the total number of If somatic mutations are important for the developoxidative hits to the DNA per cell per day in humans ment of the cystic lesions of ADPKD, which is an increasmay be more than 10 4 [49] . A number of observations ingly accepted hypothesis, then treatments capable of suggest that the severity of PKD can be modulated by reducing the rate of somatic mutations may be able to oxidative stress, and depletion of glutathione by the adslow down the progression of the disease. This could inministration of buthionine sulfoximine aggravates the clude drugs capable of preventing the activation of endevelopment of PKD in Han:SPRD rats [reviewed in dogenous and exogenous mutagens (inhibitors of phase 50]. The evidence for a protective effect of antioxidants 1 enzymes) or of enhancing their detoxication (inducers on the development of PKD is more limited. The adminof phase 2 enzymes). This approach has not yet been istration of probucol to pcy mice fed a high-protein diet tried for ADPKD. One study has demonstrated an uphad a protective effect, possibly as a consequence of its regulation of the cytochrome P450 1B1 in the Han:SPRD antioxidant action [51] . On the other hand, the dietary rat [48] . If a similar up-regulation of this enzyme could content of ␣-tocopherol, a major lipophilic antioxidant be demonstrated in other models of renal cystic disease, of cell membranes, did not have a significant effect on the severity of the PKD in Han:SPRD rats [52] . Possibly further studies to determine whether CYP1B1 can modu- other cytosolic antioxidants and antioxidant enzymes are ciated with a high-protein diet may result in an enhanced synthesis rate of adenosine 5Ј-triphosphate (ATP), but more important in the pathogenesis of PKD.
the steady-state tissue concentrations of ATP have not been found to be different [55] . Enhanced ammoniagen-DIETARY AND METABOLIC INTERVENTIONS esis, oxidative stress, and extracellular release and para-Studies in animal models of PKD have clearly demoncrine effect of ATP have all been proposed as potential strated that its development can be markedly influenced mechanisms of renal cystic disease progression in by dietary interventions. While protein restriction consis-ADPKD. In addition, alterations in dietary protein have tently ameliorates it, the administration of a high-protein been shown to alter the activity of the renal renin-angiodiet dependably aggravates renal cystogenesis in pcy tensin system and the expression of transforming growth mice and Han:SPRD rats [53, 54] . The responsible mechfactor-␤ (TGF-␤), which can also affect renal cystic disanisms are not clearly established. In the remnant kidney ease progression [53, 54] . model, a high-protein diet has been associated with a Not only the protein content, but the protein composilower arterial pH, higher intracellular pH and inorganic tion of the diet may influence the development of PKD. phosphate, higher oxygen consumption, higher genera-Soy protein-based diets have a beneficial effect on the tion of oxygen-free radicals, higher oxidized:reduced gludevelopment of PKD in the Han:SPRD rat and in the tathione ratios, and increased ammoniagenesis, while the pcy mouse, as compared with casein-based diets [56-58]. reverse occurs during protein restriction. The increased
The mechanism underlying this beneficial effect has not been established. Soy protein contains several phytoes-intracellular concentration of inorganic phosphate asso-trogens or soy isoflavones, including genistein, which is tions in the studies using a soy protein and flaxseed diet.
Possibly, autoxidation of the 3-PUFA or an oxidating an inhibitor of tyrosine protein kinases. The addition of genistein in an amount comparable to that present in a or nephrotoxic effect of the antioxidant ethoxyquin added to the fish oil preparation might have been respon-soy protein-based diet, however, did not have a beneficial effect [56] . Since soy protein has a high l-arginine/l-lysine sible for the detrimental effect. The possibility that renal ammoniagenesis or linked ratio compared with casein, the possibility exists that the beneficial effect of soy protein is related to an increased metabolic processes could have an effect on the progression of PKD was suggested by an association between production of nitric oxide [56] . However, the administration of l-arginine has been found to have only a very chronic hypokalemia and acquired renal cysts [reviewed in 64]. Acquired renal cysts are also observed in chronic modest beneficial effect on the development of renal cystic disease in the Han:SPRD rat [59] . An intriguing study renal failure, both clinically and experimentally, and in patients with distal renal tubular acidosis. Increased renal relates the beneficial effect of a soy protein diet to its effect on polyunsaturated fatty acid metabolism [58] . In ammoniagenesis, either in absolute terms or relative to the number of surviving nephrons, is common to these this study, soy feeding was associated with higher renal and hepatic linoleic acid content, higher hepatic ␣-linoleconditions. The link of an enhanced cortical production of ammonia associated with renal mass reduction, chronic nic acid, and lower hepatic arachidonic acid content, changes consistent with the reported effect of soy protein hypokalemia, and dietary deficiency of antioxidants to the development of interstitial inflammation and fibrosis feeding to decrease the hepatic activity of ⌬6-desaturase, the first step in the conversion of the essential 6-polyunin these conditions suggested that a similar mechanism could be operative in PKD, as a result of a defective saturated fatty acid (6-PUFA) to the eicosanoid precursor arachidonic acid ( Fig. 4) [60]. It has been suggested transfer of ammonia to the final urine analogous to that observed after subtotal nephrectomy [reviewed in 64]. that the beneficial effect of the soy protein may be due to the reduced production of arachidonic acid. Finally, Therefore, the demonstration that the administration of the administration of soy protein results in lower levels sodium bicarbonate or potassium bicarbonate or sodium/ of insulin-like growth factor-1 (IGF-1) in the kidneys of potassium citrate markedly attenuates the development Han:SPRD cy/ϩ rats, suggesting a role for the IGF system of PKD in the Han:SPRD rat seemed to provide a strong in its beneficial effect [61] .
rationale for the study of this safe and economical form The administration of flaxseed supplementation, a rich of treatment in human ADPKD [64, 65]. Unfortunately, source of ␣-linolenic acid, has also been reported to amethis beneficial effect has not been confirmed in other aniliorate the interstitial nephritis associated with the renal mal models of PKD. In fact, the administration of sodium cystic disease in Han:SPRD rats [62]. The mechanism rebicarbonate or sodium/potassium citrate to pcy mice has sponsible for this beneficial effect is thought to be through no beneficial effect and can be detrimental [66, 67]. More competition with linoleic acid for ⌬6-desaturase and a recently, the administration of sodium bicarbonate to reduction in arachidonic acid synthesis ( Fig. 4) [58]. In pck rats has been found to markedly aggravate the develaddition, ␣-linolenic acid is converted into eicosapentaopment of the PKD (abstract; Qian Q, 33rd ASN Meeting, noic acid (EPA), which displaces arachidonic acid from 2000). These opposing effects of base administration may the cell membranes. EPA competes effectively for availbe related to the origin of the cysts from different nephable cycloxygenase and lipooxygenase activity, and the ron segments in these animal models. In the Han:SPRD prostanoids and leukotrienes derived from EPA (3-series rats, the cysts develop from the proximal tubules. In the PGs and 5-series LTs) are less inflammatory and chemopcy mouse, the cysts originate from the distal tubules tactic than those derived from arachidonic acid [AA;
and collecting ducts. In the pck rats, the cysts derive 2-series prostaglandins (PGs) and 4-series leukotrienes from the thick ascending limb of Henle, distal tubules, (LTs)]. The beneficial effect of flaxseed may also be due to and collecting ducts. The investigation of the mechaits high content of lignans, a main class of phytoestrogens.
nisms responsible for these different responses is likely In contrast to the observations with soy protein diet to provide an insight into the role of metabolic factors and flax oil supplementation, the administration of fish in the modulation of renal cystogenesis. oil, a rich source of 3-PUFA EPA and docosahexaenoic (DHA) acids, has a long-term detrimental effect on renal ErbB RECEPTORS AND TYROSINE function and survival in pcy mice [63], despite a possible KINASE INHIBITORS early beneficial effect in the short term. The administra-A number of elegant studies during the last decade tion of a fish oil diet reduced the renal content of tissue have provided evidence for a major role for the epiderarachidonic acid, which was replaced by EPA and DHA. mal growth factor (EGF)-TGF-␣-EGF receptor (EGFR) The authors suggested that the detrimental effect might axis in promoting epithelial hyperplasia and cyst formahave been due to a reduction in renal prostaglandin E 2 production, but this seems inconsistent with the observa-tion and enlargement, and for its potential as a target tain multiple EGF or EGF-like peptides in mitogenic ment of postnatal kidney explants from bpk mice with the EGFR tyrosine kinase inhibitor EKI-785 markedly concentrations [72, 73] . The expression of TGF-␣ mRNA and protein is increased in ADPKD kidneys [73] . EGFR reduced the number of collecting tubule cysts [81] . The in vivo role for increased EGFR activity was demon-is overexpressed and mislocated to the apical surface of cystic epithelial cells in human ADPKD and ARPKD, as strated by breeding mice carrying the waved-2 mutation, a point mutation that decreases EGFR tyrosine kinase well as in the cpk, bpk, and orpk mouse models of PKD [74, 75] . Apically expressed EGFRs exhibit high-affinity activity, and orpk mice [82] . Animals homozygous for both mutant genes (orpk and waved-2) had a marked binding for EGF, autophosphorylate in response to EGF, and transmit a mitogenic signal when stimulated by the reduction in the formation of collecting tubule cysts and an improvement in renal function. Finally, the adminis-appropriate ligand. Overexpression of ErbB-2 has also been detected in a small number of patients with ADPKD tration of the novel tyrosine kinase inhibitor EKI-785 to bpk mice markedly reduced collecting tubular cystic but not in those with ARPKD [76]. Transgenic mice that overexpress TGF-␣ develop renal cystic disease and re-lesions, improved renal function, and increased the life span of these animals [75] . nal expression of TGF-␣ as a transgene accelerates the progression of the PKD in pcy mice [24, 77] . The expres-
The interest on the inhibition of EGFR extends beyond the treatment of ADPKD and is an area of intense sion of ErbB-2 as a mouse transgene causes multifocal hyperplasia of renal tubular epithelial cells and cyst for-investigation for the prevention and treatment of neoplastic diseases in many academic centers and pharma-mation [25] . EGF and TGF-␣ are cystogenic in a variety of in vitro systems [78, 79] . Treatment of murine meta-ceutical companies [83, 84] . A link between activation of EGFR and ErbB-2 receptors and human cancer has nephric organ cultures with the tyrosine kinase inhibitors tyrphostin or genistein inhibits the development of EGF been convincingly demonstrated. Several reversible and irreversible EGFR tyrosine kinase inhibitors, with excel-and TGF-␣-induced proximal tubule cyst formation in explants from normal mice and induces proximal tubule lent potency and selectivity and limited toxicity, are currently in phase 1 or phase 2 clinical trials. cyst regression in explants from bpk mice [78, 80] . Treat-
Fig. 6. Post-translational modifications of Ras required for its attachment to the plasma membrane, which is a prerequisite for its activation.

Ras INHIBITORS
in Han:SPRD cy/ϩ rats, possibly by inhibiting farnesyl synthesis and Ras farnesylation [89] . The Ras genes code for a family of guanosine triphosphate (GTP) binding proteins, with endogenous guanosine triphosphatase (GTPase) activity, which cycle be-
cAMP ANTAGONISTS AND PROTEIN KINASE tween an active GTP-bound and an inactive guanosine A TYPE 1 INHIBITORS diphosphate (GDP)-bound state and have a central role
The activation of adenyl cyclase and generation of in the cellular signal transduction cascade [85] . The par-cAMP promote the secretion of solutes and fluid into ticipation of Ras proteins in the pathogenesis of PKD is the cysts [90, 91] . Recent studies have suggested that supported by the increased renal expression of H-ras cAMP may also promote cell proliferation in polycystic and K-ras in cpk mice and human ADPKD, as well as kidneys and a variety of neoplastic tissues, including by the renal cystic phenotype of Ras transgenic mice renal cell carcinoma [92] [93] [94] . Yamaguchi et al found that [86] . The activation of Ras requires attachment to the receptor-mediated agonists of adenyl cyclase, forskolin, plasma membrane, which is dependent on a number of and 8-Br-cAMP activate the extracellular signal regupost-translational modifications (Fig. 6) . The most crulated kinase (ERK) cascade and increase cellular prolifcial of these modifications is the attachment of a farnesyl eration in cells derived from polycystic kidneys, but that group to a C-terminal cysteine by the enzyme farnesylthey had an inhibitory effect on cells derived from nortransferase, which recognizes a carboxyl terminal CAAX mal human kidney cortex [92] . The proliferative effect motif. This enzyme can be inhibited by molecules that on ADPKD derived cells was complementary and addiresemble either the 15 carbon farnesyl donor or the Ras tive to that caused by EGF. While the effect of EGF CAAX motif. Several of these drugs are currently in was blocked by genistein, a receptor tyrosine kinase inphase 1 and phase 2 clinical trials for neoplastic diseases hibitor, the cAMP-dependent proliferation was not. The and appear to have minimal toxicity [87, 88] . The possieffect of cAMP, but not that of EGF, was blocked by a bility that these drugs may be effective to treat PKD is cAMP-dependent protein kinase [protein kinase A (PKA)] suggested by the observation that the administration of inhibitor. Both effects, those of EGF and of cAMP, were lovastatin, an HMG-CoA reductase inhibitor, had a beneficial effect on the development of renal cystic disease blocked by a mitogen extracellular kinase (MEK recep-tor) inhibitor. From these observations, these authors
INHIBITORS OF PROTEIN KINASE EFFECTORS concluded that cAMP stimulates the proliferation of
The activation of Ras triggers a protein kinase cascade, ADPKD, but not normal kidney, epithelial cells by PKA which includes Raf and MEK. Kinase inhibitors of Raf activation of the ERK pathway at a place distal to the and MEK are in early stages of development, while Raf receptor tyrosine kinase and proximal to MEK (Fig. 3) .
antisense oligonucleotides are in phase 2 clinical trial for The role of cAMP and PKA on the regulation of cell a number of carcinomas, including renal cell carcinoma proliferation in a variety of neoplastic tissues, including [97] . One of the MEK inhibitors, PD-098059, has been renal cell carcinoma, has received recent attention and shown to block the proliferative effect of EGF and cAMP may be relevant to ADPKD [94] [95] [96] . The effects of on ADPKD-derived epithelial cells in vitro [92] . cAMP on mammalian cells are mediated by binding to either of two distinct isoforms of PKA, known as PKA1
INHIBITORS OF LIPID-MEDIATED SIGNALING and PKA2. PKA1 and PKA2 share identical catalytic
The activation of hormone, growth factor, and cyto-(C) subunits, but differ in the regulatory (R) subunits kine receptors is also associated with changes in phostermed R1 in PKA1 and R2 in PKA 2. The PKA holoenpholipid and sphingolipid metabolism, and results in the zyme is a tetramere formed of two identical regulatory generation of bioactive lipid signaling molecules. A numand catalytic subunits. Upon cAMP binding to the R ber of abnormalities in the levels of these bioactive lipid subunits, the active C subunits are released. The relative molecules have been described in PKD in humans and abundance of PKA1 and PKA2 isoforms is regulated in rodents. during differentiation, cell growth, and neoplastic trans-
The phosphorylated residues on the intracellular doformation. Increased levels of PKA1 are detected in neomain on the growth factor receptors bind and activate plastic and proliferating cells, whereas a predominant PLC-␥, which cleaves phosphatidylinositol (4,5)-bisphosexpression of PKA2 is found in growth-arrested cells.
phate (PIP 2 ) into diacylglycerol (DAG; Fig. 3 ). The levels There is evidence for functional cross-talk between liof PIP 2 in the kidneys of pcy mice have been found to gand-induced EGFR activation and PKA1 expression and be markedly reduced, probably reflecting an increased function. PKA1 is overexpressed and activated following PLC-␥ activity [98] . DAG activates some forms of protein TGF-␣-induced transformation in several rodent and kinase C (PKC) such as PKC-␣, which are involved in human cell lines. Ciardiello and Tortora have proposed cell proliferative processes [99] . PKC-␣ antisense oligothat EGFR and PKA1 interact by direct binding of the nucleotides and inhibitors of PKC kinase activity, which R1 subunit to the Grb2 adaptor protein, downstream are in phase II clinical trials for neoplastic disease, may of EGFR, but upstream of the ERK pathway, which is be of value to treat PKD. consistent with the observations made in ADPKD-derived
The activation of Ras results in the activation of phosepithelial cells [94] . PKA1 may also activate MEK through phatidylinositol-3 kinase (PI3K; Fig. 3 ). The product of the intermediacy of Rap-1 and B-Raf, as has been rethis reaction, phosphatidylinositol-3 phosphate (PI3P), cently been described in PC-12 and COS cells, which are is able to activate the protein kinase Akt (also known stimulated to proliferate by cAMP [reviewed in 92].
as protein kinase B or PKB), which is a suppressor of The observation that cAMP and PKA activation proapoptosis [100] . An increased formation of PI3P after motes the proliferation of neoplastic and ADPKD-derived intraperitoneal injection of 3 H-myoinositol, which probaepithelial cells has important therapeutic implications.
bly reflects the activation of PI3K, has been described A new class of cAMP analogues can discriminate bein pcy mice [98] . In addition, an increased expression of tween the two cAMP binding sites on R1 and R2, down-Akt has been observed in PKD [101] . Inhibitors of PI3K, regulate R1 by facilitating the degradation of protein, and which would be predicted to inactivate Akt and promote up-regulate R2 expression at the transcriptional level.
apoptosis, are currently in a preclinical phase of develop-One of these analogues (8-Cl-cAMP) has been shown ment [102] . to inhibit growth and induce differentiation in a variety
The binding of cytokines to their receptors can also of human cancer cell lines. Another approach in neoplastrigger the activation of sphingomyelinases. A marked tic disease has been to inhibit the synthesis and function reduction in the renal concentration of ceramide and of PKA1 by the use of R1 mRNA antisense oligonucleostriking increases in the renal concentrations of glucosyl tides. The functional cross-talk between EGFR activaand lactosyl ceramides have been reported in the cpk tion and PKA1 expression suggests that the combination mice [103]. These may reflect an increase in glucosyl ceraof EGFR tyrosine kinase inhibitors and PKA1 inhibitors mide synthase activity. The levels of glucosyl and lactosyl may have synergistic effects. In fact, anti-EGFR antibodceramide and the activities of glucosyl ceramide synthase ies and PKA1 antisense oligonucleotides have a demonand lactosyl ceramide synthase are markedly increased strated cooperative inhibitory effect on the growth of in human ADPKD kidneys and in epithelial cell cultures derived from human ADPKD and cpk kidneys [104]. renal cancer xenografts in athymic mice [95] .
Lactosyl ceramide has been found to stimulate the phos-majority of kidneys with noncystic diseases, there is a phorylation of mitogen-activated protein kinase (MAPK) very low rate of epithelial proliferation, and apoptotic in proximal tubular epithelial cells from normal human DNA fragmentation is undetectable. On the other hand, kidney [104] . The effect of drugs capable to inhibit the it is easily detectable in rodent models of PKD and husynthesis of lactosyl ceramide, such as 1-phenyl-2-decaman ADPKD, involving both cystic and noncystic renal noylamino-3-morpholino-1-propanol, on the developparenchyma [20, 21] . A marked increase in caspase ment of PKD has not been ascertained [105] .
(mainly capase 4)-mediated apoptosis has been described in kidneys of cpk mice [110] . The exact role of apoptosis RETINOIDS AND VITAMIN D with respect to cystogenesis is uncertain. A recent study in the cpk mouse has demonstrated that nuclear expres-The retinoids are a class of biologically active derivasion of Pax 2, which is normally down-regulated in matives of and synthetic compounds structurally related to ture epithelial cells, is persistent in many epithelial cells. vitamin A, which control normal cell growth, differentiation, and apoptosis during embryonic development and
Reducing the Pax 2 gene dose led to an increase in within epithelial tissues in later life [106] . They exert apoptosis and less severe cystic disease [111] . On the other their effects by binding to at least six retinoid receptors, hand, the development of renal cysts and renal failure which are classified into two subfamilies: retinoid acid in knockouts of the antiapoptotic proto-oncogenes Bcl receptors (RARs) ␣, ␤, and ␥, and retinoid X-receptors 2 and AP2-␤ suggests that accentuated apoptosis might (RXRs) ␣, ␤, and ␥ (Fig. 3) . The diversity of these recepexert a cystogenic effect. In addition, the high rate of tors and their binding to DNA as dimers explains the apoptosis in polycystic kidneys may exert a certain decomplexity of the retinoid signaling mechanisms. The gree of counterproliferative and counterprotooncogenic best studied retinoids, 13-cis-retinoid acid, 9-cis-retinoid effect, which may explain the low incidence of renal cell acid, and all-trans-retinoid acid, occur endogenously at carcinoma in ADPKD. Although multiple strategies to very low levels and have been synthesized and adminisincrease or decrease the rate of apoptosis in tubular tered at pharmacological levels. Retinoids have been used epithelial cells are possible [112, 113] , further studies are as chemopreventive agents in experimental models of needed to define unambiguously the role of apoptosis carcinogenesis, as well as in clinical trials, including chemoin cystic disease progression and the potential benefit prevention of recurrent bladder carcinoma [107]. The of treatments acting at various levels of the apoptotic focus of retinoid drug development is the synthesis of drugs with selectivity for specific retinoid acid receptors cascade. and less toxicity. One of these drugs, fenretinide, induces apoptosis in numerous neoplastic cells, has a favorable toxicity profile, has been found to be effective in rat and TAXANES mouse models of bladder carcinogenesis, and is being A role for microtubules in cystogenesis was suggested tested in large placebo-control studies of chemoprevenby the demonstration that taxol, colchicine, and vinblastion for human bladder cancer. Whether fenretinide or tin reversibly inhibited the formation of cysts by epitheother retinoids might be beneficial in the treatment of lial cells from human and murine polycystic kidneys cul-PKD has not been studied. However, the administration tured in a collagen matrix. The administration of taxol of N-(4-hydroxyphenyl) retinamide markedly inhibits to cpk mice markedly inhibited the formation of cysts and cystogenesis in cultures of ADPKD-derived Madinprolonged survival. Treatment with other microtubule Darby canine kidney, and rat epithelial cells in a collagen active taxanes was also protective to an extent propormatrix [108].
tional to their ability to bind and promote spontaneous Like the retinoids, biologically active forms of vitamin assembly of microtubules in vitro, whereas treatment with D inhibit cellular proliferation and induce differentiation and apoptosis in a variety of cells by binding to a vitamin inhibitors of DNA synthesis was ineffective [114] . The D receptor. Although the clinical use of vitamin D is mechanism by which stabilization of microtubules was limited by its calcemic effect, a number of analogues that protective in a rapidly progressive model of PKD is uninhibit cell growth without significant calcemic activity certain, but it might have been due to the promotion of have been synthesized [109] . The effect of these drugs apoptosis [115, 116] . The fact that the administration of on cystogenesis has not been evaluated.
taxol has no protective effect in Han:SPRD rats or pcy/ pcy mice with slowly progressive renal cystic disease sug-MODULATORS OF PROLIFERATION gests that taxanes are not likely to have a beneficial effect AND APOPTOSIS in human ADPKD [117] . The administration of taxol also was not protective in orpk mice, a model of ARPKD less Proliferation and apoptosis are tightly regulated during nephrogenesis. In normal mature kidneys and in the rapidly progressive than that in cpk mice [118] .
HORMONAL MODULATORS
The administration of a vasopressin V2-receptor (AVP-V2R) antagonist reduced the severity of the cystic dis-By the time the renal cysts reach a diameter of approxiease and renal insufficiency in cpk/cpk mice, a model mately 2 mm, they become disconnected from the tubular characterized by an urinary concentration defect and upsegment from which they derived. Further growth of the regulation of AVP-V2R and aquaporins 2 and 3 [122] . cysts depends on a process of transepithelial fluid secretion.
This observation may be relevant to other experimental The driving force is an active transport of chloride from models of PKD, as well as to human ADPKD and the basolateral to the apical side. The potential energy ARPKD, in which there is also a urinary concentration for chloride secretion is developed by the sodium pump defect. Anecdotal observations suggest that the inhibi-(Na ϩ ,K ϩ -ATPase) located in the basolateral membranes tion of secretin release induced by the administration of of cyst epithelial cells. The chloride entry mechanism H 2 blockers or by octreotide might have a beneficial into the basolateral membrane is a sodium-potassiumeffect on polycystic kidney and liver disease. Neverthechloride, bumetanide-sensitive, cotransporter (NKCC1 or less, a small prospective study with octreotide failed to BSC2), which utilizes the gradient established by the demonstrate a benefit [123] . sodium pump to bring K and Cl into the cells. Net chloride transport is accomplished by opening chloride channels within the apical membrane. Chloride ions flow ANTI-INFLAMMATORY AGENTS down an electrochemical gradient into the cyst generat-Interstitial inflammation is a consistent finding that ing increased transepithelial electron activity that in turn develops early and contributes to the progression of the drives sodium ions through ion selective paracellular renal cystic disease in murine models of PKD and in pathways. An apical chloride channel that may play a human ADPKD. It is accompanied by local expression role in cyst fluid accumulation is the cystic fibrosis transof chemokines, lymphokines, and other inflammatory membrane conductance regulator (CFTR). This is supmediators [reviewed in 45] . The chemokines are a large ported by the up-regulation of CFTR in some cysts, by family of secreted, chemotactic, basic proteins of 8 to whole cell patch clamp studies of ADPKD-derived epi-10 kD molecular weight selectively targeting different thelial cells, by the CFTR antisense oligonucleotideleukocyte subpopulations. They have been divided acinduced inhibition of fluid secretion in cyst-derived cell cording to their chemical structure into the C-X-C [for monolayers, and by the observation of a milder cystic example, interleukin-8 (IL-8)], C-C [monocyte chemophenotype in two patients affected by both ADPKD and tactic protein 1 (MCP-1)] and C (for example, lymphocystic fibrosis [119] . On the other hand, attenuation of the toxin) chemokines. Osteopontin is a highly acidic, secystic phenotype was not observed in a third patient with creted glycoprotein that also exhibits chemoattractant ADPKD and cystic fibrosis (abstract; Persu A, 33rd ASN activity for macrophages. IL-8, MCP-1, and osteopontin Meeting, 2000) and CFTR does not seem to be important are expressed at low levels in normal renal tubule epithein the autosomal recessive murine orpk model of cystic lial cells. In Han:SPRD rats, MCP-1 and osteopontin are disease (abstract; Nakanishi T, 33rd ASN Meeting, 2000) . expressed at very high levels, primarily over the cystic The activation of the NKCC1/BSC2 cotransporter and epithelium. Elevated plasma concentrations of IL-6 have of the chloride channels is regulated by PKA-mediated been reported in patients with ADPKD. High levels of phosphorylation, which is under hormonal control. The the proinflammatory cytokines tumor necrosis factor-␣ secretion of chloride and fluid by cyst-derived epithelial (TNF-␣), IL-1, and IL-2 have been found in cyst fluids cells is stimulated by a number of agonists that stimulate from patients with ADPKD [reviewed in 45]. TNF-␣, a the production of cAMP, such as vasopressin, secretin, major mediator of inflammation and a strong inducer vasoactive intestinal peptide, prostaglandin E1 and E2, of other cytokines, is produced as a 26 kD membraneand cyst activating factor (CAF). Secretin has been shown associated precursor protein that requires proteolytic to increase the rate of fluid secretion in vivo in renal cleavage to the soluble 17 kD active protein. The TNF-␣and hepatic cysts of subjects with ADPKD [120]. In converting enzyme (TACE) responsible for this proteoaddition, testosterone has been found to activate adenyllytic cleavage belongs to the family of metalloproteicyclase, increase cellular cAMP, and stimulate the secrenases. Most metalloproteinase inhibitors have limited tion of chloride and fluid by monolayers of MDCK cells, potency against TACE, but more selective inhibitors possibly contributing to the gender dimorphism obcurrently under development and other strategies for served in human ADPKD and rat models of PKD [121] .
inhibiting TNF-␣ may be of interest in the treatment of The molecular mechanisms by which fluid is secreted ADPKD (discussed later in this article) [124, 125] . The by cyst-derived epithelial cells can potentially be tarimportance of inflammation in the pathogenesis of geted for treatment. Whether the inhibition of the baso-ADPKD is highlighted by studies in which methylpredlateral NKCC1/BSC2 cotransporter by loop diuretics nisolone, a steroidal anti-inflammatory that inhibits phospholipase A 2 and cyclooxygenase-2 (COX-2), atten-might be of therapeutic value has not been ascertained. uated renal enlargement and renal dysfunction in two and the degree to which they may contribute, not only to the development of hypertension and vascular lesions, but rodent models of renal cystic disease [126] . Whether other anti-inflammatory drugs, such as COX-2 inhibitors also to the proliferation of the cystic epithelium and interstitial inflammation and fibrosis, have been reviewed or lipooxygenase inhibitors, might have protective effects on the development of PKD that outweigh their elsewhere [45] and are only briefly summarized here.
There is convincing evidence that the intrarenal renin-potential toxicity has not been ascertained.
angiotensin system is activated in human ADPKD, as well as in experimental models of PKD, as least in the INHIBITORS OF MATRIX early stages. The administration of a converting enzyme METALLOPROTEINASES inhibitor or an angiotensin II type 1 (AT-1) receptor an-Matrix metalloproteinases are a group of zinc depentagonist to Han:SPRD cy/ϩ rats between 3 to 4 weeks and dent enzymes that include the interstitial collagenases 10 to 20 weeks of age has had a protective effect on the (MMP-1, MMP-8, and MMP-13), stromelysins (MMP-3 severity of the renal cystic disease and renal function as and MMP-10), gelatinases (MMP-2 and MMP-9), and compared with other antihypertensive regiments [129] [130] [131] . membrane-type metalloproteinases [127] . They are in-On the other hand, enalaprilat and hydralazine adminisvolved in the remodeling and turnover of the extracellutered to Han:SPRD rats between 3 and 40 weeks of age lar matrix and have been implicated in the pathogenesis were equally protective on the renal function as reflected of PKD by controlling matrix degradation and growth by the level of serum creatinine, although only enalaprifactor activation. While the levels of tissue inhibitors lat reduced proteinuria and kidney size [131]. of MMPs (TIMPS) have been found to be uniformly Elevated plasma levels and the presence of endothelin elevated in tissues or cultured cells from human polycysin cyst fluid have been demonstrated in human ADPKD tic kidneys or livers and in renal tissues from Han:SPRD [132, 133] and cpk/cpk mice [134] . Elevated renal tissue rats or cpk mice, the observations on MMPs have been levels of endothelin 1 have been found in Han:SPRD less consistent [reviewed in 123]. A recent study has shown rats. On the other hand, the expression of endothelin elevated serum or plasma levels of MMP-1, MMP-9, and type A and type B receptors has been found to be in-TIMP-1 in patients with ADPKD [128] . MMPs are also creased in the cpk/cpk mouse, but reduced in the Han: thought to play an important role in tumor invasion, SPRD rat. Endothelin-1 (ET-1) transgenic mice have metastases, and angiogenesis. A number of selective ina cystic phenotype [135] . The acute administration of hibitors of specific MMPs are currently in phase 1, 2, or bosentan, a mixed endothelin receptor antagonist, sig-3 clinical trials for a variety of neoplastic diseases [127] .
nificantly decreased the mean arterial blood pressure Treatment of Han:SPRD rats with batimastat, a broad and glomerular filtration rate and increased the renal blood flow in Han:SPRD rats, but had no significant spectrum MMP inhibitor, has had a beneficial effect on effect in the control rats [136] . Whether the chronic adcyst number and kidney weight (abstract; Obermuller ministration of endothelin antagonists might have a pro-N, Netherlands PKD Workshop, 2000) . Recently, specific tective effect on the development of PKD has not been TACE inhibitors have been reported to inhibit TGF-␣ ascertained. secretion from immortalized cystic collecting tubule cells Little is known on the role of nitric oxide (NO) in the in vitro and cystogenesis in bpk mice in vivo (abstract; pathogenesis of ADPKD. Nitric oxide has potentially Dell K, 33rd ASN Meeting, 2000) . Therefore, the role of beneficial (preservation of renal blood flow and glomeru-MMPs in the pathogenesis of ADPKD and their potenlar filtration, inhibition of platelet adherence to endothetial as a target for intervention deserve further study. lial surfaces) and detrimental (cytotoxicity from oxidative damage) effects. Both beneficial and detrimental effects TREATMENT OF HYPERTENSION AND from NO inhibition have been described in a variety of NEPHROANGIOSCLEROSIS experimental models of glomerular disease and acute renal Hypertension often develops early in the course of failure [reviewed in 59]. The administration of l-arginine ADPKD and is a predictor of renal functional decline.
in the rat remnant kidney model, which is characterized It is accompanied by an increase in renal vascular resisby a reduced renal generation of NO, has produced varitance and filtration fraction, resetting of the pressureable results: protective at a low and detrimental at a high natriuresis relationship, salt sensitivity, and normal or dose. The renal production of NO has been found to be increased extracellular fluid volume, plasma volume, and reduced in Han:SPRD rats (abstract; Wang D, 33rd ASN cardiac output. It is accompanied by severe sclerosis of Meeting, 2000) [58] . The administration of the NO synthase the preglomerular vessels, even early in the course of the inhibitor N G -nitro-l-arginine methyl ester (L-NAME) and disease. Therefore, early detection and treatment of hyl-arginine had only a modest, gender-dependent (obpertension are of the upmost importance in management served only in the male animals) overall effect on the severity of the cystic disease [59] . On the other hand, of these patients. The role of the different vasoactive factors 
